<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03450577</url>
  </required_header>
  <id_info>
    <org_study_id>IBS</org_study_id>
    <nct_id>NCT03450577</nct_id>
  </id_info>
  <brief_title>International Bifurcation Study</brief_title>
  <acronym>IBS</acronym>
  <official_title>International Prospective Register on Treatment of Coronary Artery Bifurcation Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meshalkin Research Institute of Pathology of Circulation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meshalkin Research Institute of Pathology of Circulation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The IBS registry is an observational, multi-center, real-world registry of stenting in
      coronary bifurcation lesions that will collect information on procedures and outcomes from
      various participating centers.

      The aim of this registry is to investigate long-term clinical results and predictors of
      adverse outcomes after PCI for coronary bifurcation lesions among various participating
      centers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with coronary bifurcation lesions, if they meets all the study inclusion criteria
      and none of the exclusion criteria, after signing the informed consent, they will underwent
      PCI according to the current standard of care and will be entered in the registry. Follow-up
      for all subjects will continue for 5 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Procedural success</measure>
    <time_frame>1 day</time_frame>
    <description>Achievement of technical success and with no in-hospital major adverse cardiac events</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac and Cerebrovascular Events</measure>
    <time_frame>6 months, 1 year, 3 years, 5 years</time_frame>
    <description>Death, myocardial infarction (MI), target vessel revascularization (TVR), or stroke.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>6 months, 1 year, 3 years, 5 years</time_frame>
    <description>All of the deaths that occur in a study group, regardless of the cause.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death from cardiac causes</measure>
    <time_frame>6 months, 1 year, 3 years, 5 years</time_frame>
    <description>All deaths will be assumed cardiovascular in nature unless a non-cardiovascular cause can be clearly provided (e.g. malignancy, trauma, and infection).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>6 months, 1 year, 3 years, 5 years</time_frame>
    <description>The presence of electrocardiography findings indicative of ischemia that were not related to the index procedure, as well as chest discomfort associated with creatinine kinase-myocardial band fraction or troponin-T/troponin I greater than the upper limit of normal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularization</measure>
    <time_frame>6 months, 1 year, 3 years, 5 years</time_frame>
    <description>Repeat PCI of the lesion within 5 mm of stent deployment or bypass graft surgery of the target vessel.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>6 months, 1 year, 3 years, 5 years</time_frame>
    <description>Sudden occlusion of a stented coronary artery due to formation of thrombosis.According to the Academic Research Consortium was defined as definite, probable, or possible.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Coronary Bifurcation Lesion</condition>
  <arm_group>
    <arm_group_label>PCI of bifurcation lesions</arm_group_label>
    <description>Patients who have undergone bifurcation coronary artery stenting.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI of bifurcation lesions</intervention_name>
    <description>Different approaches for treatment of bifurcation coronary artery disease.</description>
    <arm_group_label>PCI of bifurcation lesions</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with coronary bifurcation lesion treated during PCI
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18 years

          -  Any type of bifurcation lesion in major epicardial artery

        Exclusion Criteria:

          -  Patient refused informed consent to participate in the registry
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dmitrii Khelimskii, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Meshalkin National Medical Research Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dmitrii Khelimskii, MD</last_name>
    <phone>+79137069256</phone>
    <email>dkhelim@mail.ru</email>
  </overall_contact>
  <location>
    <facility>
      <name>Meshalkin National Research Center</name>
      <address>
        <city>Novosibirsk</city>
        <state>Novosibirskaya Oblast</state>
        <zip>630055</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dmitrii Khelimskii, MD</last_name>
      <phone>+79137069256</phone>
      <email>dkhelim@mail.ru</email>
    </contact>
    <contact_backup>
      <last_name>Aram Badoyan, MD</last_name>
      <phone>+79039319889</phone>
      <email>soir007@yandex.ru</email>
    </contact_backup>
    <investigator>
      <last_name>Dmitrii Khelimskii, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aram Badoyan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oleg Krestyaninov, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <link>
    <url>http://meshalkin.ru</url>
  </link>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 5, 2018</study_first_submitted>
  <study_first_submitted_qc>February 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 1, 2018</study_first_posted>
  <last_update_submitted>February 28, 2018</last_update_submitted>
  <last_update_submitted_qc>February 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 1, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meshalkin Research Institute of Pathology of Circulation</investigator_affiliation>
    <investigator_full_name>Dmitrii Khelimskii</investigator_full_name>
    <investigator_title>Dmitrii Khelimskii</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

